The Richard C. Longworth Media Fellowship Program 2022-2023 is now accepting applications. The goal of this fellowship, which is a collaboration with the Chicago Council on Global Affairs, is to encourage Chicago and Midwest journalists to report on foreign issues. The fellowships are funded by a grant from The Clinton Family Fund in memory of Richard C. Longworth, a former Chicago Tribune foreign correspondent who is now a Distinguished Fellow at the Chicago Council. For the next two years, two scholarships will be offered to journalists concentrating on global challenges that affect Chicago and Midwestern readers and viewers.
About the Scholarship:
Pfizer Inc. (Pfizer) is a global biopharmaceutical corporation founded on research. Biopharmaceutical products are discovered, developed, manufactured, marketed, sold, and distributed by the company. Medicines and vaccines are part of the company’s global portfolio. The company develops health, prevention, treatments, and cures across markets. To support and offer access to healthcare, it collaborates with healthcare providers, governments, and local communities. Its medications and vaccines benefit healthcare providers and patients by treating diseases and improving health and wellness. Wholesalers, retailers, hospitals, clinics, government agencies, and pharmacies are all customers for its prescription pharmaceutical items. It sells vaccines to the federal government, the Centers for Disease Control and Prevention (CDC), wholesalers, single provider offices, retail pharmacies, and integrated delivery networks in the United States. Pfizer, one of the world’s leading pharmaceutical corporations, became a household name in 2020 when the FDA approved its COVID-19 vaccine for use for the first time. The CDC is now recommending the Pfizer vaccination for children aged 5 to 11 starting in early November 2021. Many parents have been waiting for the green light to vaccinate their young children, and this is good news. The company was founded in Williamsburg, Brooklyn, New York, and is still headquartered there. During World War II, the company’s first great achievement was in creating penicillin, which was in short supply. Pfizer continued to expand, and in 1980, it released Feldene, an anti-inflammatory medicine that became the company’s first $1 billion product. Before 2000, the firm grew by marketing medications like Zoloft, Lipitor, Norvasc, and Viagra, and has subsequently achieved unparalleled levels of success through a series of acquisitions and the creation of a consumer healthcare division.
Pfizer is certainly worth a lot of money — $215.2 billion to be exact — but its stock hasn’t appreciated much in the last year. Pfizer’s stock was worth $30.97 at the close of business on March 1, 2020. It’s been hovering around $40-$50 in recent months, finishing out November 2 at $45.45. The business became the first to get an emergency use license for a COVID-19 vaccine from the FDA in December 2020. In response to the spread of the COVID-19 Delta variant, the CDC and other health officials stated that a booster shot will be offered for Americans who are completely vaccinated with the Pfizer vaccine starting the week of Sept. 20, 2021. The FDA authorized the Pfizer-BioNTech vaccine on Aug. 23, 2021, and it will now be marketed as Comirnaty. Eliquis, Enbrel, EpiPen, Depo-Provera, Dimetapp, Neosporin, Xeljanz, and Zithromax/Zmax are all manufactured by Pfizer. It specializes in cancer, heart, and diabetes medicines, as well as vaccines. It also makes drugs for endocrine (hormone) and nervous system problems. Pfizer is dedicated to improving health and well-being at every stage of life by utilizing science and their global resources. They have a leading portfolio of healthcare products that support wellness and prevention, as well as treatment and cures for diseases across a broad range of therapeutic areas; and they have an industry-leading pipeline of promising new products with the potential to combat some of the world’s most feared diseases. They are focused on improving the way they do business, operating with transparency in everything they do, and listening to the views of all people involved in health care decisions to ensure they can continue to deliver on their commitments to the patients, customers, and shareholders who rely on them. Their objective is to ensure that people everywhere have access to new therapies and quality health care by collaborating with everyone from patients to health care providers and managed care organizations to world governments and non-governmental organizations.
The corporation is owned by its shareholders and operates in 180 countries. Groton, Connecticut is where the company’s research headquarters are located. It employs about 96,000 individuals all across the world. Despite this, several experts advise investors to put their money into Pfizer. The company has had problems with its legacy pharmaceuticals as well as recent clinical trials on a breast cancer drug, but the success of the COVID-19 vaccination is expected to lift the stock.
Scholarship Sponsor(s): Pfizer
Scholarship Country: United States
Scholarship Worth: $10,000
Study Level: Postgraduate
Nationality: International Students
Each year, two $10,000 fellowships are given out. In June, the winners will be announced.
Eligibility for Scholarship
- The competition is open to print, broadcast, and online journalists based in Chicago or the Midwest.
- Staff and freelance journalists are both able to apply.
- Field reporting should take place in international areas, and issues should be timely and relevant to Chicago and Midwest audiences.
- Proposed projects must have a credible plan for wide distribution of the final product in Chicago or other Midwestern news media (print, online, and/or broadcast).
- Both staffers and freelancers should be able to show editors and/or producers that they are invested in their work. For freelancers, an applicant’s track record working with the mentioned sources is usually the most telling indicator of a distribution plan’s legitimacy.
- Editors should not merely write letters declaring that they will consider the work. Editors and/or producers who have previously worked with you and are interested in working with you again are urged to write letters.
The Richard C. Longworth Media Fellowship Program 2022-2023 for Journalists in Chicago is open to all international students
Are you both interested and qualified? To apply, go to www.tfaforms.com and type in Pfizer.
The following items must be included in your application:
- In no more than 250 words, describe the planned project and schedule.
- A rough financial breakdown, including travel, ground transportation, hotel, meals, visas, and local reporting partner/translator expenses.
- Plan for distribution.
- Three examples of work that has been published in print or on television.
- There are three professional references available. Contact information or letters of recommendation can be included. When letters from interested producers or editors are available, the latter is encouraged.
- Please provide a copy of your curriculum vitae.
- A more extensive description of the project may be included in the application, but it will be treated as an optional addition only. The 250-word summary is the most significant aspect of the submission.
The application deadline for Richard C. Longworth Media Fellowship Program 2022-2023 for Journalists in Chicago is May 2, 2022